Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

CapsoVision, Inc (CV) Cash Flow Statement

CapsoVision, Inc (CV) generated -$27.8M of operating cash flow over the twelve months to 2026-06-30, spent $68000 on capital expenditure and had free cash flow of -$27.9M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CVCapsoVision, IncFollow CV — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
349.8M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
12 Nov, in 19 days
LineFY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-20.1-22.9-27.8
Capital expenditure0.20.1-0.1
Free cash flow-20.2-23.0-27.9
Stock-based compensation0.20.8—

USD millions · SEC XBRL

CapsoVision, Inc — questions

What is CapsoVision, Inc's operating cash flow?
-$27.8M over the twelve months to 2026-06-30.
How much does CapsoVision, Inc spend on capital expenditure?
$68000 over the twelve months to 2026-06-30.
What is CapsoVision, Inc's free cash flow?
-$27.9M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from CapsoVision, Inc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.